Pimagedine

Pimagedine

SCHEMBL728583

N=C(N)NN.N=C(N)NN.O=S(=O)(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Pimagedine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA known ✓ P21397 1/20 0.39
MAOB known ✓ P27338 1/20 0.39
KDM4E B2RXH2 3/20 0.48
BLM P54132 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CA5A P35218 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39
LMNA P02545 2/20 0.37
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
NT5E P21589 1/20 0.35
CA4 P22748 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pimagedine SCHEMBL439903 1.00 KDM4E (0.48) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL28939705 0.97 KDM4E (0.46) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL9702626 0.97 KDM4E (0.46) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL4259785 0.90 KDM4E (0.46) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL4821332 0.90 KDM4E (0.46) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL9797617 0.90 TSHR (0.50) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL27731082 0.89 ALDH1A1 (0.53) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL30862143 0.83 LMNA (0.43) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL30862137 0.83 CYP2C19 (0.40) KDM4EBLMCYP2D6CYP2C19NPSR1
Pimagedine SCHEMBL7763659 0.82 ALDH1A1 (0.43) TSHRCYP1A2NFKB1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1493453-B1 Absorbent comprising coated super-absorbent polymer particles PROCTER & GAMBLE (US) 2010-12-22 EP claimed
US-7311968-B2 Absorbent structures comprising coated super-absorbent polymer particles THE PROCTER & GAMBLE COMPANY (US) 2007-12-25 US claimed
WO-1992004302-A1 GUANIDINE AS A NITROGEN FERTILIZER THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 1992-03-19 WO claimed
CN-111912838-B BNP chemiluminescence detection kit and application thereof 宁波瑞源生物科技有限公司 2023-05-12 CN disclosed
CN-112512498-A Hair cosmetic 花王株式会社 2021-03-16 CN disclosed
US-10633332-B2 Guanidine compounds for removal of oxyanions from aqueous solutions and for carbon dioxide capture UT-BATTELLE, LLC (US) 2020-04-28 US disclosed
US-20190010118-A1 GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE UT-BATTELLE, LLC (US) 2019-01-10 US disclosed
US-20180134655-A1 GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE U.S. DEPARTMENT OF ENERGY 2018-05-17 US disclosed
US-8791320-B2 Absorbent structures comprising coated super-absorbent polymer particles THE PROCTER & GAMBLE COMPANY (US) 2014-07-29 US disclosed
EP-1654012-B1 WATER-SWELLABLE MATERIAL COMPRISING COATED WATER-SWELLABLE POLYMER PARTICLES BASF SE (DE) 2013-04-24 EP disclosed
US-8137746-B2 Elastomers THE PROCTER & GAMBLE COMPANY (US) 2012-03-20 US disclosed
US-20050014933-A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2005-01-20 US disclosed
US-20050003191-A1 Absorbent structures comprising coated super-absorbent polymer particles THE PROCTER & GAMBLE COMPANY (US) 2005-01-06 US disclosed
EP-1493453-A1 Absorbent comprising coated super-absorbent polymer particles The Procter & Gamble Company (US) 2005-01-05 EP disclosed
EP-1453858-A1 PROCESS FOR RENATURATION OF RECOMBINANT, DISULFIDE CONTAINING PROTEINS AT HIGH PROTEIN CONCENTRATIONS IN THE PRESENCE OF AMINES Bayer HealthCare AG (DE) 2004-09-08 EP disclosed
WO-2003044055-A1 PROCESS FOR RENATURATION OF RECOMBINANT, DISULFIDE CONTAINING PROTEINS AT HIGH PROTEIN CONCENTRATIONS IN THE PRESENCE OF AMINES BAYER HEALTHCARE AG (DE) 2003-05-30 WO disclosed
EP-1314739-A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines BAYER AG (DE) 2003-05-28 EP disclosed
WO-1992004302-A1 GUANIDINE AS A NITROGEN FERTILIZER THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 1992-03-19 WO disclosed
WO-1992004302-A1 GUANIDINE AS A NITROGEN FERTILIZER THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 1992-03-19 WO disclosed
US-4479917-A Use of aminoguanidine compounds as oxygen-scavenging and corrosion-inhibiting agents OLIN CORPORATION (US) 1984-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014933-A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines SPR, P4HB, WIZ MAOA 2539/4885MAOB 1796/4885KDM4E 4448/4885
US-20190010118-A1 GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE GUCY1A1, GUCY1A2, GUCY1B1 MAOA 431/4885MAOB 438/4885KDM4E 1102/4885
US-10633332-B2 Guanidine compounds for removal of oxyanions from aqueous solutions and for carbon dioxide capture GUCY1A1, GUCY1A2, GUCY1B1 MAOA 431/4885MAOB 438/4885KDM4E 1102/4885
US-20180134655-A1 GUANIDINE COMPOUNDS FOR REMOVAL OF OXYANIONS FROM AQUEOUS SOLUTIONS AND FOR CARBON DIOXIDE CAPTURE GUCY1A1, GUCY1A2, GUCY1B1 MAOA 431/4885MAOB 438/4885KDM4E 1102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.